Prior to the advent of tyrosine kinase inhibitors (TKIs), which block the activity of the BCR::ABL oncoprotein, Ph+ ALL was treated with chemotherapy alone, and the prognosis was poor [4]. Here, BCR is linked to acute lymphoblastic leukemia.